Form 4 for FLNA FILANA THERAPEUTICS, INC.
Accepted 2022-04-25 00:00:00 ET · period of report 2022-04-25 · accession 0001069530-22-000019 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMI | 2022-04-25 | 2022-04-25 | FLNA | BARBIER REMI | Pres, CEO, Dir | M - OptEx | $2.40 | +49.5K | 371.4K | +15% | +$118.7K |
| DMI | 2022-04-25 | 2022-04-25 | FLNA | BARBIER REMI | Pres, CEO, Dir | M - OptEx | $1.63 | -49.5K | 5,209 | -90% | -$80.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-25 | M | A | 4,669 | $16.31 | 376,112 | I By Family | — | — | (F1) Transaction represents exercise of stock options for cash. |
| 2 | Common | Common Stock | 2022-04-25 | M | A | 44,791 | $0.95 | 371,443 | I By Family | — | — | (F1) Transaction represents exercise of stock options for cash. |
| 3 | Derivative | Common Stock | 2022-04-25 | M | D | 4,669 | $16.31 | 0 | I By Family | $16.31 · 2016-12-07 to 2022-12-07 | 4,669 Common Stock | |
| 4 | Derivative | Common Stock | 2022-04-25 | M | D | 44,791 | $0.1 | 5,209 | I By Family | $0.95 · 2022-04-14 to 2028-09-14 | 44,791 Common Stock |